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MHM is a chicken Z chromosome-linked locus that is methylated and transcriptionally silent in male
cells, but is hypomethylated and transcribed into a long non-coding RNA in female cells.MHM has been
implicated in both localised dosage compensation and sex determination in the chicken embryo, but
direct evidence is lacking. We investigated the potential role of MHM in chicken embryonic develop-
ment, using expression analysis and retroviral-mediated mis-expression. At embryonic stages, MHM is
only expressed in females. Northern blotting showed that both sense and antisense strands of theMHM
locus are transcribed, with the sense strand being more abundant. Whole mount in situ hybridization
conﬁrmed that the sense RNA is present in developing female embryos, notably in gonads, limbs, heart,
branchial arch and brain. Within these cells, the MHM RNA is localized to the nucleus. The antisense
transcript is lowly expressed and has a cytoplasmic localization in cells. Mis-expression of MHM sense
and antisense sequences results in overgrowth of tissues in which transcripts are predominantly
expressed. This includes altered asymmetric ovarian development in females. In males, MHM
mis-expression impairs gonadal expression of the testis gene, DMRT1. Both MHM sense and antisense
mis-expression cause brain abnormalities, while MHM sense causes an increase in male-biased embryo
mortality. These results indicate that MHM has a role in chicken normal embryonic development,
including gonadal sex differentiation.
& 2012 Elsevier Inc. All rights reserved.Introduction
The chicken embryo has a ZZ male: ZW female sex chromo-
some system. The Z-linked gene, DMRT1, is required for testis
development during embryonic development and is hypothesized
to operate via gene dosage, with males (ZZ) having two doses and
females (ZW) having one (reviewed in Chue and Smith, 2011).
Z-linked DMRT1 is more highly expressed in testes versus ovaries,
and knockdown of DMRT1 expression leads to feminization of
male gonads (Smith et al., 2009). It is therefore postulated that
DMRT1 is a key gene underlying sex determination in the avian
system. The higher expression of DMRT1 in male tissues (ZZ)
suggests that the gene escapes a dosage compensation mechan-
ism. Indeed, birds lack a chromosome wide Z-inactivation system
analogous to X chromosome inactivation in mammals (Baverstockll rights reserved.
earch Institute, Royal
a.
ith).et al., 1982; Kuroiwa et al., 2002; Ellegren, 2007; Itoh et al., 2007).
On average, most Z-linked genes show mRNA expression levels
that are greater than 1.5 fold higher in males (ZZ) compared to
females (ZW), as assessed by microarray and individual gene
expression studies (Kuroda et al., 2001; McQueen et al., 2001; Itoh
et al., 2007; Zhang et al., 2010) reviewed in Arnold et al. (2008).
However, there are regions across the Z chromosome that are
compensated, or partially compensated (McQueen et al., 2001;
McQueen and Clinton, 2009). These regions may harbor genes
that are developmentally important and for which dosage
inequality between the sexes cannot be tolerated.
A speciﬁc cluster of compensated genes has been reported on
chicken Zp (Melamed and Arnold, 2007). Within this region is a
gene called MHM (Male HyperMethylated). MHM is hypermethy-
lated on the two Z sex chromosomes of male chickens and is
transcriptionally silent. Treatment of male cells with the
demethylating agent, 5-aza-cytidine, alters chromatin conﬁgura-
tion and allows MHM expression in male cells (Itoh et al., 2011).
In female cells (ZW), the MHM locus is hypomethylated on the
single Z chromosome and is transcribed into a long non-coding
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(Teranishi et al., 2001; Itoh et al., 2011). The MHM sequence may
mediate the partial dosage compensation seen on the chicken Z
chromosome, either locally or more widely. In mammals, X
inactivation is regulated by the X-linked gene, Xist (Leeb et al.,
2009). While not structurally related to Xist, MHM shows similar
features, encoding a high molecular weight non-coding RNA
which coats one of the sex chromosomes in cis. It has therefore
been speculated that MHM could speciﬁcally mediate dosage
compensation of the Zp gene cluster in chicken, dubbed the
‘‘MHM valley’’, by modifying local chromatin organization
(Arnold et al., 2008; Teranishi et al., 2001). However, whereas
Xist is associated with X inactivation, MHM is associated with an
active Z sex chromosome. Within this same region on the female
Z sex chromosome, histone 4, lysine 16 is acetylated (Bisoni et al.,
2005). In other dosage compensation systems, histone acetylation
is associated with up-regulation of neighbouring genes (Bone
et al., 1994; Smith et al., 2005). A causal relationship between
MHM and H4k16 acetylation is unclear. However, taken together,
these observations have led to the hypothesis that MHM plays a
role in dosage compensation by altering gene expression in
females (ZW). It may do so by up-regulating a subset of genes
on the female Z chromosome (those in the ‘‘MHM valley’’) to
equalise dosage with that of males (ZZ), via a process that
involves local female-speciﬁc hyperacetylation of histone H4k16.
The DMRT1 locus is adjacent to the MHM valley, and it has also
been hypothesized that MHM RNA could function to repress
DMRT1 expression in female embryos, thereby contributing to
sex determination in the chicken (Teranishi et al., 2001;
Yang et al., 2010). To further explore the role of MHM in chicken
embryonic development, we carried out detailed expression and
mis-expression studies. We ﬁnd that RNA transcription occurs
from both the sense and antisense strands of the MHM locus and
that these strands have different temporal and spatial expression
patterns during embryonic development. Furthermore, mis-
expression of these sequences causes embryonic abnormalities
of the brain and gonads, consistent with a role in both dosage
compensation and sex determination in the chicken embryo.Methods
Cloning of the chicken 2.2 kb MHM repeat unit
The Chicken (Gallus gallus)MHM locus, ﬁrst described by Teranishi
et al. (2001), comprises a core BamHI- 2.2 kb repeat that has at least
200 copies on the short arm of the Z sex chromosome. The transcript
itself was estimated at 9 kb. Using this sequence data, we designed
primers to amplify the 2.2 MHM sequence as described by Teranishi
et al. (2001) (Genbank AB046698). A 2.2 kb PCR product obtained
from chicken genomic DNA was cloned into pSLAX shuttle vector
and its identity conﬁrmed by automated sequencing. This sequence
was then subcloned into the RCASBP(A) avian retroviral vector for
mis-expression studies (Logan and Tabin, 1998).
Northern blot analysis
A 668 base pair MHM riboprobe, derived from the 2.2 kb
sequence, was used for Northern blotting. Total RNA was isolated
from several embryonic day 10.5 male and female gonad, limb
and brain samples and approximately 10 mg of each were run on a
1.1% agarose/formaldehyde gel, together with RNA size standards
(Promega Corp, Madison, WI, USA). RNA was transferred to a
Hybond N membrane (Amersham Biosciences, UK) by capillary
transfer and baked at 80 1C for two hours. Membranes were
prehybridized with Ultrahyb (Ambion, Austin, Texas, USA) forone hour at 68 1C and then probed with 100 ng DIG-labelled
probe overnight at 68 1C. MHM sense transcripts were detected
with the 668 bp MHM antisense riboprobe, synthesized with SP6
RNA polymerase, while the MHM-antisense strand was detected
on a separate membrane, using the sense probe (T7 RNA poly-
merase). The next day, membranes were washed to a stringency
of 0.1 standard saline citrate (SSC) and 0.1% sodium dodecyl
sulfate (SDS) at 68 1C. Bound DIG-labelled riboprobe was detected
using an anti-DIG antibody (Roche, Mannhein, Germany). Chemi-
luminescent signal generated by CDP-Star (Roche) substrate was
detected by exposure of membranes to Kodak Hyperﬁlm (Amer-
sham Biosciences, UK). Northern blots were performed twice.
Chemiluminescent exposure time for the sense transcript was
1 min, while exposure for the antisense transcript was over
90 min.
Whole mount in situ hybridization
One hundred fertile chicken eggs were incubated at 37.8 1C
and embryos were harvested throughout development. The whole
mount in situ hybridization method (WISH) has been described in
detail previously (Andrews et al., 1997; Smith et al., 1999).
Embryos were sexed by PCR as described previously (Clinton
et al., 2001), prior to manipulation of tissues for expression
analysis. At least three embryos were used for each analysed
time point. Brieﬂy, tissues were dissected under RNase-free con-
ditions and ﬁxed overnight at 4 1C in 4% paraformaldehyde/PBS.
Whole embryos (early stages) or isolated tissues were taken.
Following ﬁxation, tissues were dehydrated through a methanol
series, and stored at 20 1C prior to rehydration and digestion
with proteinase-K in PBSþ0.1% Triton-X 100 (30 to 90 min,
depending upon the size of tissues). Samples were then brieﬂy
re-ﬁxed, and incubated overnight at 65 1C in prehybridisation
buffer. Two different RNA probes were used in experiments that
were repeated at least twice. In the ﬁrst set of experiments, the
same 668 bp fragment used for Northern blotting was used for
WISH. The antisense probe (detecting MHM-sense) was synthe-
sized using SP6 RNA polymerase and labeled with digoxygenin
(DIG). The DIG ‘‘sense’’ probe (detecting MHM-antisense) was
synthesized with T7 RNA polymerase. In the second experiment,
the entire 2.2 kb repeat unit was used as a riboprobe. Probes were
added to tissues overnight in hybridsation solution, washed at
1 and 0.1 strigency, and alkaline-phosphatase conjugated
DIG antibody was added, following pre-blocking in TBTX buffer
(pH 7.0) containing BSA and sheep serum. Tissues were then
extensively washed in TBTXþ0.1% BSA, and the chromagen was
then added (NBT/BCIP in Tris-based buffer, pH 9.0). Color reac-
tions were carried out at room temperature over 2–4 h, prior to
imaging. For sectioning, tissues were placed back into chromogen
solution and incubated at room temperature over two days, then
cryoprotected by placing into 30% sucrose/PBS overnight at 4 1C.
Following embedding in OCT compound and snap freezing on dry
ice, tissue samples were cut on a cryostat at 10–18 mm and
mounted onto slides with Aquamount. In some cases, tissues
were treated with DAPI prior to mounting, allowing the visualiza-
tion of RNA signals relative to the nucleus, followed by false
coloring of the RNA signal against DAPI blue immunoﬂourescence.
Mis-expression of 2.2 kb MHM in ovo
To assess the effects on mis-expressing MHM, the RCAS
avian viral vector was used (Fekete and Cepko, 1993; Logan and
Tabin, 1998) (Smith et al., 2009). The 2.2 kb BamHI MHM unit
(Genbank AB046698) was subcloned from pSLAX shuttle plasmid
into RCASBP/A proviral DNA and its sequence conﬁrmed. The
viral DNA was transfected into chicken ﬁbroblastic DF1 cells and
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Fig. 1. Potential open reading frames (ORFs) in each frame identiﬁed from 2376 bp
MHM sequence, AB046698. MHM-Sense sequences 50 30 (blue). MHM-antisense
30 50 (green). The position of the 668bp riboprobe sequence used in this study is
shown in red. The longest potential ORFs are approximately 400 bp. (For interpreta-
tion of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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level of expression of MHM (not shown). Virus was harvested
from culture medium, concentrated by ultracentrifugation and
titred. High titer virus (at least 108 Infectious Units/mL) was injected
into day 0 blastoderms, eggs were sealed with paraﬁlm and devel-
opment allowed to proceed at 37.8 1C. Control embryos were either
not injected, or injected with RCASBP/A virus carrying GFP. These
experiments were repeated and involved at least 50 embryos for each
experiment. Embryos were generally harvested at embryonic days
10.5 (stage 35). Infection was conﬁrmed by staining tissues with p27
antibody, which detects a viral epitope. Tissues were examined
for macroscopic abnormalities, and assessed using either WISH or
immunostaining or qRT-PCR for DMRT1 and MHM gene expression.
Immunostaining and histology
Control and MHMmis-expressing tissues were ﬁxed for 15 min
in 4% PFA/PBS at room temperature, prior to processing for tissue
section immunoﬂuorescence, as described previously (Smith et al.,
2003). At least three embryos per time point and/or treatment
were examined. Brieﬂy, 10 mm sections were cut of a cryostat,
permeablised in PBSþ1% Triton X-100 and blocked in PBSþ2%
BSA. Primary antibodies were raised in-house (rabbit anti-DMRT1
and rabbit Aromatase, both 1:5000) or were obtained commer-
cially (rabbit anti-p27; Charles River Services; 1:1000). Alexa-ﬂuor
secondary antibodies were used (donkey or goat anti-rabbit 488 or
594; Molecular Probes). Sections were counterstained with DAPI.
For histology of brain samples, tissues were ﬁxed overnight in
Bouin’s ﬂuid, dehydrated in a tissue processor, embedded in
paraﬁm and cut on a microtome at 6 mm. Sections were staining
in haematoxylin and eosin prior to mounting in DPX and imaging.Quantitative reverse transcription-PCR (qRT-PCR)
RNA was extracted from isolated gonads, reverse transcribed
as previously described (Smith et al., 2008). Probes were designed
UPL Assay Design Center (https://www.roche-applied-science.
com) and are as follows. MHM antisense probe 159 together with
forward primer 50-CTC TCA TTC CGG CTT CCA-30 and reverse
primer 50-TTG TTT TTG TTT GGC CAG TG-30; MHM sense probe 15
with forward primer 50-CAA AGC GCT TGA AAG GGT AA 30 and
reverse primer 50-GCA AAG AAC TAC TCG CCA AAA; DMRT1 probe
59 together with forward primer 50–AGC CTC CCA GCA ACA TAC
AT-30 and reverse primer 50-GCG GTT CTC CAT CCC TTT-30; HPRT
probe 38 together with forward primer 50–CGC CCT CGA CTA CAA
TGAA TA-30 and reverse primer 50-CAA CTG TGC TTT CAT GCT
TTG-30; Cytokeratin probe 162, together with forward primer
50-ACT CTG CTC CAG GCA TTG AC-30 and reverse primer 50-TCA CGG
TTC AGC TCC TCA G-30; 18S rRNA probe 48, together with forward
primer 5-GCA ATT ATT CCC CAT GAA CG-3 and reverse primer
50-GGG ACT TAA TCA ACG CAA GC-30. Analysis was performed using
LightCycler 480 instrument, LC480 master mix and software
(Roche). Relative expression was determined using the compara-
tive CT method (DDCT), with samples normalized against either
18S rRNA or HPRT and expressed as fold change. In addition, the
efﬁciency of each primer/probe combination was determined and
only combinations with efﬁciencies 480% were used.Results
MHM-sense and MHM-antisense sequences.
Teranishi et al. (2001) ﬁrst described the MHM transcript as a
9 kb RNA, containing a 2.2 kb repeat unit. This unit is reiterated onthe chicken Z sex chromosome (Genbank accession number
AB046698). We ampliﬁed a 2.2 kb sequence from chicken gDNA,
which corresponded to this sequence, shown in Fig. 1. MHM is
thought to encode a long non-coding RNA. However, there are
several short potential open reading frames derived from both
sense and antisense strands, the longest being approximately 420
bp (MacVector software, Accelrys). These could potentially encode
small bioactive peptides. In the studies described here, a 668 bp
RNA probe was designed against a region within the 2.28 kb MHM
RNA sequence, as shown in Fig. 1. The UCSC genome browser
indicates that there are several splice variants of the MHM
sequence. Indeed, Northern blot analysis of embryonic tissues
revealed a number of female speciﬁc transcripts, in both the sense
and antisense orientations, (Fig. 2). Several transcripts of varying
sizes derived from the sense strand were detectable in female
tissues (from 1.7 kb to over 12 kb), with the most abundant
species being of higher size (7 kb and above). No transcripts were
detected in males (Fig. 2(A)). The MHM sense strand studied here
is identical to the original MHM sequence as published by
Teranishi et al. (2001) (clone pCC1-11). However, the MHM
sequence present on the Genbank database (AB046689.1) is in
the opposite orientation with respect to our sequence. The MHM
antisense strand was also expressed female-speciﬁcally, but at
much lower levels and with different sized transcripts. (Northern
blot chemiluminescent exposure time was 1.5 h for MHM-anti-
sense versus an exposure time of 1 min for the MHM sense strand).
Spatial expression of MHM
Whole mount in situ hybridization (WISH) and tissue section-
ing was used to examine MHM sense and antisense strand
expression in whole embryos at embryonic day (E) 1, 2 and
4 and in isolated urogenital systems up to day 8.5 (Figs. 3 and 4).
Both the 668 bp and 2.2 kb riboprobes gave the same overall
staining patterns. While both sense and antisense strands were
expressed in a female-speciﬁc manner, the sense strand showed
MHM (sense strand)
MHM (antisense strand)
Fig. 2. Northern blot analysis of day 10.5 embryonic gonad (G), limb (L) and brain
(B) total RNA. (A) MHM sense strand expression. Ethidium bromide staining showing
equal loading in female and male samples as indicated by the 28S and 18S bands. Five
RNAs are detected in female but not male tissues, at 1.8 kb, 3.6 kb, 7 kb, 9 kb and over
12 kb. (B)MHM antisense strand expression. 28S and 18S bands stained with ethidium
bromide indicate equal loading. Weak bands are detectable in female tissues, notably
at 3.4 kb and 1.8 kb. Additional bands are present in brain (arrowheads).
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Fig. 3. Female-speciﬁc expression of MHM sense RNA, using either 0.668 kb or
2.2 kb riboprobe. (A) Whole embryo expression, delineated with a 2.2 kb MHM
riboprobe. Expression in female embryos is detected ﬁrst throughout from day 1.
Strong expression is seen by day 4. Males do not show expression. (B) MHM
expression in the urogenital system, using the 668 bp riboprobe. Expression is
detectable in female gonads (G, outlined), in the Mu¨llerian duct (arrowhead) and
at lower levels in the mesonephros (Ms), from day 4.5–8.5. Gonadal expression
increases over time. No expression is detectable in male gonads.
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Strong female-speciﬁc expression ofMHM sense strand was detected
throughout embryos (Fig. 3). Expression was ﬁrst detectable in
whole embryos after day 1, throughout the body (Fig. 3(A)). How-
ever, speciﬁc tissues showed higher MHM sense expression than
others. These included the brain, branchial arches, heart and the
urogenital system. In the urogential system, MHM sense was
expressed in the (female) gonads, with expression increasing over
development, from day 4 to at least day 8 (Fig. 3(B)). Lower level
expression was also observed in the female mesonephric kidneys.
No MHM sense expression was detected in males.
The antisense MHM strand was also expressed, but at lower
levels and with a more restricted pattern. It was ﬁrst detected at
E1 (stage 10) in the developing neural tube of the female (Fig. 4).
By E4.5, MHM-sense expression was observed in the developing
female brain and limbs (Fig. 4(A)). In the urogenital system,
MHM-antisense was weakly expressed in the gonads (Fig. 4(B)).
Localization of MHM expression in embryonic gonads
Given the previous suggestion that MHM RNA could inﬂuence
gonadal sex differentiation, we examined gonadalMHM expression inmore detail. Tissues stained during whole mount in situ hybridization
were cryo-protected and sectioned. In gonads examined at embryo-
nic day 6.5 and 10.5, punctate MHM sense RNA localisation was
detected throughout both left and right gonads and in mesonephric
kidneys of female embryos (Fig. 5(A)). A similar pattern was seen in
sectioned brains (not shown). High power magniﬁcation of the RNA
signal suggested nuclear localization, which was conﬁrmed by DAPI
nuclear counterstaining (Fig. 5(A)). This nuclear expression pattern
was observed with both the 688 bp and the 2.2 kb riboprobes
detecting MHM sense. Such punctate nuclear RNA staining is quite
distinct from the diffuse cytoplasmic staining typical of mRNA ISH.
There appeared to be a single focus of localization within each
nucleus. In contrast, the MHM-sense strand was present in the
cytoplasm of the developing ovarian cortex of female gonads
(Fig. 5(B)) with weak staining detected in scattered cells of the
underlying medulla. (Embryonic day 10.5 tissues are shown.) The
cortex is the site of germ cell proliferation and folliculogenesis, and
the medulla is the site of oestrogen biosynthesis. Counterstaining of
some sectioned whole mount specimens with DAPI to delineate the
nucleus, followed by false colouring of the RNA signal, clearly
conﬁrmed the MHM-antisense staining to be cytoplasmic. This con-
trasts with the nuclear staining for MHM-sense. No speciﬁc staining
for either MHM-sense or MHM-antisense could be detected in male
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Fig. 4. Female-speciﬁc expression of MHM-antisense RNA. (A) MHM-antisense RNA
expression in day 1 female embryos. At E4.5, expression is detectable in the
telencephalon (Tel) and mesencephalon (Mes) of the brain, and in the fore-
and hindlimbs. Males did not show expression. (B) Low level-MHM-antisense
expression in the gonads (G) outlined in white. Ms¼mesonephric kidneys.
Weak expression observed from day 4.5 in the females with stronger expres-
sion observed at 6.5 and 8.5. Little expression is observed in the males. Scale
bar¼50 mm.
MHM RNA in male gonads  
E10.5 left testis  (sense)        left testis (antisense)              
MHM-antisense RNA in female gonads 
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M
E6.5 female gonad 
MHM-sense RNA in females gonads (2.2kb riboprobe)
E6.5 female mesonephros DAPI counterstain (E10.5) 
E10.f female left gonad E10.5 female right gonad DAPI counterstain (E10.5) 
Fig. 5. Localization of MHM sense and antisense transcripts in E10.5 gonads, using
0.668 kb or 2.2 kb riboprobe. (A) Punctate expression of MHM-sense in a E6.5
female gonad and in the neighboring mesonephric kidney (insert shows nuclear
localization). DAPI counter-staining conﬁrms a nuclear localization in E10.5 ovary
(arrows). (B)MHM-antisense expression in the cytoplasm of the left ovarian cortex.
(C ) and in scattered medullary cells (M). The right gonad lacks a cortex and shows
medullary staining only. False DAPI counterstaining for nuclei (blue) shows that
MHM-Forward is cytoplasmic (red). Bar¼100 um. (C) No speciﬁc staining for
either RNA in E10.5 testis. (For interpretation of the references to colour in this
ﬁgure legend, the reader is referred to the web version of this article.)
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over-stained male samples (so-called ‘‘edge effects’’, Fig. 5(C)).
Mis-expression of MHM in female embryos
MHM-sense was mis-expressed in ovo by injecting day 0 blas-
toderms with RCAS virus expressing the 2.2 kb MHM repeat unit.
This procedure leads to widespread expression of the trans-
gene throughout the embryo (Smith et al., 2009). Phenotypic effects
were assessed either at E4.5 (stage 28) or E10.5 (stage 35). We
originally hypothesised that mis-expression of MHM sequences in
male embryos (in which the gene is normally silent) would have
phenotypic consequences. In fact, mis-expression of MHM-sense
induced abnormalities in both sexes. The major defects observed
were perturbation of normal gonadal differentiation, brain defects
and a general overgrowth of tissues. In females, both MHM-sense
and antisense over-expression disrupted the normal asymmetric
development of the gonads (Fig. 6). Viral delivery of MHM sense
and antisense strands in developing urogenital systems was
conﬁrmed by WISH (Fig. 6). Typically, control female gonads are
asymmetrical at E10.5, marked by a large left ovary and regres-
sing right gonad (Fig. 6(A) and (B)). MHM-sense mis-expression in
embryonic female gonads prevented the normal regression of the
right gonad, resulting in the development of bilateral enlarged
ovaries. Both of these ovaries were signiﬁcantly larger than
normal asymmetric female gonads (Fig. 6(B)). Both left and right
MHM-sense infected ovaries expressed aromatase, a medullarymarker, and had thickened outer cortex, as shown in Fig. 6(B).
Immunohistochemical detection of viral p27 antigen (Fig. 6(B))
conﬁrmed robust expression of virus and the transgene in these
tissues. The enlarged ovaries of the MHM-sense over-expressing
females gonads had an increased proliferation index, according to
PH3 staining (not shown). Interestingly, the same ovarian over-
growth was observed in female embryos over-expressing MHM-
antisense RNA (Fig. 6(B)). As for MHM sense, the antisense strand
induced bilateral ovary formation in female embryos, with robust
aromatase enzyme expression delineating two enlarged ovaries.
As for MHM-sense, MHM antisense delivery into tissues was
conﬁrmed by viral p27 staining and WISH for the expressed
MHM-antisense (Fig. 6).Mis-expression of MHM sequences in male embryos
MHM is not normally expressed in male embryos, due to
epigenetic silencing (refer to Fig. 2). To assess the effects of
MHM mis-expression on male embryos, qRT-PCR, whole mount
staining and immunoﬂuorescence were used on embryonic day
10.5 samples. For both MHM sense and antisense sequences, mis-
expression perturbed testis development but did not induce
Fig. 6. Effects of MHM-sense and antisense mis-expression in day 10.5 female
chicken embryos. (A) MHM in situ hybridization following MHM sense and MHM
antisense mis-expression. (B) Lack of gonadal asymmetry and production of
bilateral ovaries in MHM sense and antisense infected female embryos. Aromatase
enzyme immunoﬂuorescence delineated bilateral enlarged ovaries. Viral P27
staining conﬁrmed robust virus infection in these gonads. UGS¼urogenital system;
lg¼ left gonad; Rg¼right goand; Ms¼mesonephric kidneys.
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mortality.MHMwhole mount in situ hybridization showed modest
but detectable mis-expression of MHM sense strand RNA in male
gonads, compared to controls, which lacked MHM-sense expres-
sion (Fig. 7(A)). This established that virally-delivered exogenous
MHM-sense sequence in males was not silenced, unlike the
endogenous copies of this gene. However, mortality was high
among these males infected with virus carryingMHM sense, and it
is postulated that those males expressing high levels of exogenous
MHM were those died (see Table 1). Among the surviving males,
which had a relatively low level of MHM sense mis-expression,
DMRT1 mRNA levels were not signiﬁcantly different to those of
controls, showing a normal pattern of male enrichment compared
to females at E10.5 (Fig. 7(A) and (B)). However, lower levels of
DMRT1 protein were variably detected in developing testes,
compared to controls. Aromatase, a female marker, was not
expressed in these male gonads mis-expressing MHM sense
(as assessed by immunoﬂuorescence; not shown). MHM sense
therefore perturbed gonadal DMRT1 protein expression but did
not induce male-to-female sex reversal.
Successful mis-expression of MHM-antisense in male embryos
was also conﬁrmed by qRT-PCR and whole mount in situ hybri-
dization. Higher levels of MHM antisense mis-expression were
achieved compared to MHM-sense (Fig. 7(C)). Mis-expression of
MHM antisense caused a signiﬁcant drop in DMRT1 mRNA levels
compared to controls, with correspondingly reduced proteinlevels, as assessed by immunoﬂuorescence (Fig. 7(D)). In females,
a modest but insigniﬁcant fall in DMRT1 was also noted. Other
autosomal genes were also tested for changes in expression level
following MHM antisense mis-expression (Cytokeratin, HPRT) but
these RNAs were not affected (not shown). This indicates that the
effect of MHM antisense was speciﬁc to DMRT1and not a global
effect on all genes.
MHM mis-expression and brain development
Both MHM-sense and MHM-antisense mis-expression induced
brain abnormalities, in both sexes (Fig. 8). For example, MHM-
sense and antisense expression were not detected in male brains
infected with control RCASBP-GFP virus at E4.5 or 10.5 (Fig. 8),
and brain structure appeared normal. MHM-sense or antisense
mis-expression was readily visualised in males by WISH staining
(Fig. 8), with brain deformities observed in these samples.
The brains were characterised by enlarged telencephalon, diencepha-
lon and mesencephalon. At E10.5 eye defects and exencephaly
were also observed (Fig. 8). A similar result was obtained for
female brains (not shown). H & E staining showed grossly
abnormal brains in MHM-infected embryos compared to controls,
with impaired ventricle development, by day 10.5 (Fig. 8). Other
tissues, such as the heart, showed overgrowth. This is shown in
Fig. 8, where WISH conﬁrmed MHM-antisensemis-expression in a
E10.5 male heart that was larger relative to the control (RCASBP-
GFP) male heart.
Mis-expression of MHM-antisense increases embryo lethality
Mis-expression of the MHM sense strand induced increased
male-biased embryonic mortality. Typically, injection of RCAS
viral vectors carrying a non-toxic transgene, such as GFP, causes
approximately 30–35% at embryonic day 10.5. This is unrelated to
the gene being expressed (Table 1). The mis-expression of MHM
antisense strand speciﬁcally caused 53% mortality among male
embryos, signiﬁcantly higher than the percentage mortality seen
in RCAS.GFP or RCAS.MHM antisense infected males. (Fishers
exact test). Female embryos did not show this increased mortality
(Table 1).Discussion
MHM is a chicken Z-linked gene that is hypermethylated and
silent in male cells but hypomethylated and expressed in female
cells, although its role in development is unclear. The studies
reported here reveal a potential role for MHM in regulating
embryonic growth and gonadal development. In embryonic
chicken tissues, the MHM locus is transcribed in both sense and
antisense directions. Our expression analysis conﬁrms previous
reports that MHM is expressed exclusively or predominantly in
female cells (Teranishi et al., 2001;Itoh et al., 2011). However, the
MHM-sense and MHM-antisense sequences have different and
dynamic expression proﬁles in female tissues. In their original
study reporting the presence of MHM on the chicken Z chromo-
some, Teranishi et al. (2001) described the expression pattern of
the sense sequence. In that study, the MHM sequence was found
to be transcribed in a strand speciﬁc fashion, with only the sense
strand being synthesized and localizing to the nucleus of embryo-
nic ﬁbroblasts. We have expanded this expression analysis,
conﬁrming nuclear localization of the RNA, and showing that it
is expressed throughout the developing embryo, but most
strongly in brain and urogenital system. This expression pattern
was ﬁrst delineated with a 668 bp riboprobe. When the in situ
hybridization studies were repeated with the entire 2.2 kb repeat
Fig. 7. Effects of MHM mis-expression on male (testis) development and DMRT1 expression. (A) Quantiﬁcation of MHM sense mis-expression by qRT-PCR and in situ
hybridization. Immunostaining for DMRT1 showed lower protein levels in MHM sense vs control testes. (B) No Effect of MHM antisense mis-expression on DMRT1 mRNA,
but DMRT1 protein staining (red) is lower in gonads mis expressing MHM-sense. Immunostaining showed lower levels of DMRT1 protein in MHM-antisense vs control
testes. (C) Quantiﬁcation ofMHM-antisense expression by qRT-PCR and in situ hybridization. Mis-expression is detected in both sexes. (*o0.01; **o0.001; unpaired t-test).
(D) Mis-expression of MHM-antisense reduces DMRT1 mRNA (*o0.01) and protein (red staining). (For interpretation of the references to colour in this ﬁgure legend, the
reader is referred to the web version of this article.)
Table 1
Effects ofMHMmis-expression on embryo mortality among embryonic day 10.5 chicken embryos. Number of dead embryos as a percentage of total embryos infected with
virus expressing MHM sense or MHM-antisense at day 0 (blastoderm stage). Total survival rate is also shown. Male embryos mis-expressing MHM sense showed greater
mortality compared to GFP control males (bold value¼statistically signiﬁcant between the two ratios; Fisher’s Exact test, two tailed p¼0.0497).
Embryos GFP control þMHM sense þMHM antisense
PCR Sex Male n¼29 Female n¼20 Male n¼78 Female n¼95 Male n¼55 Female n¼44
Embryo lethality (%)
Lethality 9 (31.0) 6 (30.0) 42(52.5) 37(39.0) 17(30.9) 15(34.1)
Survival rate 34 (69.4) 94 (54.3) 67 (67.7)
K.N. Roeszler et al. / Developmental Biology 366 (2012) 317–326 323region as a probe, the same expression pattern was recorded, with
some additional staining in the branchial arches of female
embryos. We describe here that the MHM antisense strand was
also transcribed, albeit at much lower levels, with restricted
expression in brain, limbs and urogential system. The nuclear
localization of MHM sense strongly supports the idea that it is a
non-coding RNA, and that it has a function directly associated
with chromosomal DNA. In contrast, the antisense strand is
cytoplasmic and may therefore be translated into a protein.Northern blotting with a 668 bp probe derived from the core
2.2 kb repeat unit of MHM detected several differently sized
transcripts. One of these transcripts corresponds to the 9 kb high
molecular weight species described by Teranishi et al. (2001).
In that study, a single band was detected in Northern blots of
ﬁbroblasts derived from female chicken embryos and in male
embryos when treated with the demethylating agent, 5-azacyti-
dine. In our study, several other larger and smaller transcripts
were detected in various tissues. These may represent splice
Fig. 8. Brain abnormalities following MHM mis-expression in day 4.5 and 10.5
chicken embryos. Male control and MHM-antisense mis-expressing embryos are
shown. (Comparable results were obtained for MHM-sense strand). The control
male brain at day 4.5 shows normal morphology and no MHM expression. In
embryos infected with MHM-antisense, mis-expression is detcted in the tele-
ncephalon (Tel), diencephalon (De) and in the mesencephalon (Mes). By day 10.5,
abnormal exencephaly is seen in MHM-antisense infected embryos. H and E
staining of MHM-misexpressing embryos shows failure of normal ventricle
development. Embryos misexpressing MHM-antisense also have enlarged hearts.
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described by Itoh et al. (2011). The 668 bp riboprobe used here
for Northern blotting has sufﬁcient homology to the MHM-related
sequences (64B7H1 and 28F4D2) to have detected these tran-
scripts in addition to MHM. However, in situ hybridization
analysis using the entire 2.2 kb sequence as a probe showed the
same nuclear signal as the 688 bp probe, strongly suggesting that
all of these related sequences are non-coding RNAs.
We observed widespread MHM-sense expression in developing
female embryos, with particularly strong expression in brain and
gonads, while MHM-antisense had a lower and more restricted
expression pattern (compare Figs. 2 and 3). The more widespread
expression of MHM sense is consistent with a role in dosage
compensation in most or all cells. Mis-expression of this sequence
causes general enlargement of tissues and brain defects. These
effects may reﬂect a perturbation of a subset of genes that are
normally required to be dosage compensated, especially those
expressed in the brain. A number of MHM-sense transcripts were
detected in the embryonic brain, as assessed by Northern blotting
(Fig. 2). This is consistent with previous reports of MHM expres-
sion in embryonic chicken brains (prior to gonadal sex differ-
entiation) (Scholz et al., 2006). Mis-expression of MHM-sense and
antisense sequences caused exencephaly of the brain in many
embryos of both sexes. The exencephaly was characterized by
greatly expanded cerebral hemispheres, and abnormal folding,
and thickened neuroepithelium. The exact role of MHM in devel-
opment is unknown, but evidence is now strong that it encodes a
long-non coding RNA which correlates with both open chromatin
and histone acetylation in female cells (Itoh et al., 2011), all of
which point to a role in dosage compensation of Z-linked genes.
Any perturbation of this system would lead to aberrant gene
expression. Hence, the effects ofMHMmis-expression in the brain
could be due to abnormal elevation of gene expression, namely, in
those genes that are normally subject to dosage compensation via
MHM-induced up-regulation (those in the so-called MHM valley
of the Z sex chromosome). Under this hypothesis, elevated gene
expression would cause defects in both sexes. This idea could be
tested by examining the expression level of genes within the
MHM-valley of embryos over-expressing MHM-sense. It is inter-
esting to note that the MHM valley is reported to be enriched forgenes associated with cellular physiology, reproduction and
development and developmental disorder (Melamed and Arnold,
2007).
However, a key point that has arisen from our studies is the
mechanism of action of exogenous MHM. In our studies, MHM
was mis-expressed using the RCAS avian retroviral vector. This
vector integrates randomly into the genome at the blastoderm
stage. It therefore presumably does not directly target exogenous
MHM sequence to its native location on the Z and hence would
only affect those genes in the neighborhood of the viral genomic
integration site (anywhere in the genome, and varying from
embryo to embryo). Hence, random integration of the viral vector
into the genome could produce variable effects, depending upon
which group of neighbouring genes was affected by the exogen-
ousMHM. This assumes that MHM RNA only coats DNA at the site
of transcription, in cis, but it could potentially act in trans. The
tissue-speciﬁc effects of mis-expression that we report here are in
fact consistent with a trans function for MHM, that is, an effect
upon speciﬁc developmental pathways irrespective of the site of
exogenously delivered MHM integration. One approach to test
this assumption is to infect chicken cells in vitro with RCAS-viral
delivered MHM, generate monoclonal lines of cells with the same
genomic integration site, determine the site of integration by
inverse PCR, and assess the expression levels of adjacent genes.
The alternative possibility is that MHM acts in trans, on genes
distant to its site of transcription. It is interesting that mis-
expression of MHM-antisense produced the same brain over-
growth abnormalities. MHM-antisense was found it localize in
the cytoplasm, implying a different function to the sense strand.
How both strands can induce qualitatively similar abnormalities
in the brain is unclear.
Mis-expression of MHM sequences also resulted in gender-
speciﬁc effects in the gonads. The female urogenital system is
normally asymmetrical, characterized by a large left ovary and a
smaller regressed right gonad (Fig. 6(B)). MHM-sense mis-expres-
sion induced variable hypertrophy of the gonads, resulting in
enlarged bilateral ovarian development (Fig. 6(B)), demonstrating
that ectopic MHM-sense prevented the normal regression of the
right female gonad, instead stimulating ovarian differentiation.
The right ovary appeared morphologically identical to a normal
left ovary, with a well-developed, aromatase-positive medulla
and thickened outer cortex. Both the left and right ovaries of these
embryos were considerably larger than control left ovaries. This
suggests that MHM-sense may be involved in regulating the
normal growth and asymmetry of the female urogenital system.
The exact mechanism involved is unknown, but warrants further
examination. As for brain development, MHM-antisense had the
same effect as the sense strand on ovarian development. Gonads
were not masculinised but developed symmetrically.
In male control embryos, MHM is not expressed in the gonads,
according to in situ hybridization, while the viral vector delivered
modest ectopic expression (Fig. 7(A)). The overall structure of the
developing testis was not greatly affected, and male gonads were
not feminised (aromatase was not expressed), as would be
predicted if MHM had a repressive effect upon DMRT1 mRNA
expression (Teranishi et al., 2001; Yang et al., 2010). However,
DMRT1 protein staining was reduced in MHM sense–infected
male embryos compared to controls. This suggests that MHM is
inﬂuencing DMRT1 synthesis as the post-transcriptional level, or
that MHM is having an effect upon the morphogenesis of testis
cords, or the actual number of Sertoli cells expressing DMRT1.
Similarly, mis-expression of MHM-antisense in male embryos
caused a decline in both gonadal DMRT1 mRNA and protein. This
effect was variable among embryos, which could reﬂect the
inherent variability of the viral vector at delivering robust trans-
gene mis-expression. However, as for MHM-sense mis-expression,
K.N. Roeszler et al. / Developmental Biology 366 (2012) 317–326 325overall testis structure was maintained and the female marker,
aromatase, was not activated. Hence, gonads were not feminized.
The 2.2 kbMHM sense and antisense strands may therefore have the
ability to perturb DMRT1, but not completely repress the gene. It is
possible that the 9 kb MHM transcript may show more marked
effects upon the developing testis, but due to technical limitations
of the RCAS viral vector, we were unable to express this larger
transcript. Another possibility is that more extensive inhibition of
DMRT1 may have occurred in those male embryos in which
increased lethality occurred, presumably due to very high MHM-
sense levels.
An association between MHM and chicken sex determination
has been proposed by previous studies. It has previously been
hypothesized thatMHM RNA could contribute to the repression of
DMRT1 expression in female embryos by inducing local chromatin
modiﬁcation, reinforcing the sexually dimorphic proﬁle of this
key sex gene. MHM RNA accumulates on the female Z chromo-
some very close to the DMRT1 locus (Teranishi et al., 2001).
A recent study of adult chickens reported the down-regulation of
DMRT1 gene expression following transient transfection of
13-week old chicken testes with a plasmid vector expressing the
2.2 kb MHM sequence (Yang et al., 2010). Hence, although most
studies infer that the MHM transcript could lead to up-regulation
of neighbouring genes as a dosage compensation mechanism, this
putative role for MHM-sense invokes down-regulation of the
DMRT1 gene. In addition, Yang and colleagues recently reported
the effects of experimental sex reversal on the methylation status
of MHM in adult chickens (Yang et al., 2011). In that study,
female-to-male sex reversal was achieved by treating embryos at
day 3 with an aromatase enzyme inhibitor, which blocks oestro-
gen synthesis. As adults, these ZW male birds showed enhanced
methylation of the MHM locus in the gonads, but not in the liver.
This indicates that the regulation of MHM may be different
between tissues, pointing to potential link between gonadal
development and the activity of the MHM locus. Presumably,
male factors activated by the inhibition of oestrogen, or a loss of
female factors, can leads to enhanced epigenetic modulation of
MHM in the gonad, compatible with testis development.
The method of gene mis-expression used here delivers the
transgene to all tissues of the embryo. Our aim was to closely
mimic endogenous MHM expression, which is detectable in
several tissues from early stages of development. Despite robust
delivery of the virus to all tissues, as assessed by viral p27 epitope
staining, abnormalities were seen in speciﬁc tissues (primarily,
the brains and gonads). This suggests that the endogenous role of
MHM (forward and reverse sequences) relates to brain and gonad
development. The different subcellular localization patterns of
MHM-sense and MHM-antisense suggest that the two sequences
have different functions. The locus is potentially complex.
A number of different transcripts have now been identiﬁed for
the sense strand, including some with intron-exon structure, some
with little homology outside a core region, and some with poly A
tails (Itoh et al., 2011). Nevertheless, our 2.2 kb probe showed
RNA localization within the nucleus, suggesting a common mode
of action for MHM-related sequences that involves non-coding
RNA-chromatin interaction. Mis-expression of both sense and
antisense strands induced similar phenotypes, namely, brain
and gonadal abnormalities. It is possible that the two strands
may interact with each other, for example, by inducing expression
of the opposite strand, hence inducing the similar mis-expression
phenotypes. This would be reminiscent of the interaction between
mammalian Xist and its antisense transcript, Tsix (Lee et al., 1999,
Luikenhuis et al., 2001). IfMHM functions to elevate local expression
of Z-linked genes that are developmentally important, as part of a
dosage compensation mechanism (Arnold et al., 2008, McQueen and
Clinton, 2009), mis-expression may elevate such gene expression tothe point of lethality, which would be more detrimental in males
(ZZ), as was found here. This could be tested in vitro, by examining
Z-linked gene expression cells over-expressing MHM-antisense
versus MHM-sense.
The data presented here provide the ﬁrst report of a bidir-
ectionally expressed long non-coding RNA in an avian system, and
the functional analysis of these sequences. Our results indicate
that the MHM locus is transcribed from both sense and antisense
strands in chicken embryos, with several different transcripts
expressed in female tissues. The sense RNA strand is located
exclusively in the nuclei of female cells in all tissues that were
examined. In contrast, the antisense strand is more lowly
expressed, and has an intriguing cytoplasmic localization. This
establishes theMHM locus as a complex region, with both strands
having potential roles in development. Furthermore, Itoh et al.
(2011) recently reported differences between the two MHM loci
on the Z sex chromosomes of male chicken ﬁbroblastic cells, in
terms of methylation sensitivity and potential chromatin status.
Current investigations to further analyse MHM will focus on
RNA interference, with the aim of knocking down endogenous
expression in cultured cells and in ovo, and then assaying global
gene expression by microarray. If MHM plays a role in local
dosage compensation, changes in expression of MHM-valley
genes would be predicted. The exact mode of action of MHM,
and whether it participates in dosage compensation or sex
determination, or both, requires further analysis. There is a
growing body of evidence linking long non-coding RNAs in local
gene silencing (Mercer et al., 2009) (Ponting et al., 2009) This
would be the proposed mode of action of MHM upon the
neighboring DMRT1 gene. Yet MHM is also implicated in dosage
compensation, in a way that would involve up-regulation, not
down-regulation, of neighboring genes. The possible role of long
non-coding RNAs in gene activation is less well understood (Dean,
2006). Further analysis of MHM in a tractable model such as the
avian embryo will enhance our understanding of long non-coding
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